In Brief: NSI Papnet
This article was originally published in The Gray Sheet
NSI Papnet: Neuromedical Systems, Inc. enters agreement with MagnaCare/MagnaHealth under which procedures conducted with NSI's Papnet automated Pap smear rescreening system will be covered through the physician provider network. MagnaCare covers approximately 3 mil. people, one quarter of whom will receive Papnet testing, NSI estimates. Charging $30-$40 per test, NSI anticipates generating monthly sales of $30,000 as a result of the pact...
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.